135 related articles for article (PubMed ID: 35389296)
1. Risk factors of infection of totally implantable venous access port: A retrospective study.
Guan X; Yan H; Zhang J; Li Y; Zhou Y
J Vasc Access; 2023 Nov; 24(6):1340-1348. PubMed ID: 35389296
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factor for infection of totally implantable venous access port.
Chang TC; Yen MH; Kiu KT
Langenbecks Arch Surg; 2022 Feb; 407(1):343-351. PubMed ID: 34550464
[TBL] [Abstract][Full Text] [Related]
3. Late complications associated with totally implantable venous access port implantation via the internal jugular vein.
Tsuruta S; Goto Y; Miyake H; Nagai H; Yoshioka Y; Yuasa N; Takamizawa J
Support Care Cancer; 2020 Jun; 28(6):2761-2768. PubMed ID: 31724073
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors of Infection and Role of Antibiotic Prophylaxis in Totally Implantable Venous Access Port Placement: Propensity Score Matching.
Nezami N; Xing M; Groenwald M; Silin D; Kokabi N; Latich I
Cardiovasc Intervent Radiol; 2019 Sep; 42(9):1302-1310. PubMed ID: 31187229
[TBL] [Abstract][Full Text] [Related]
5. Silver-Mixed Port Reduces Venous Access Port Related Infection Rate Compared to Non-Silver-mixed Port: A Single-center Retrospective Analysis.
Suzuki T; Michimoto K; Hasumi J; Kisaki S; Hasegawa Y; Fujimori A; Yoshimatsu L; Ashida H; Ojiri H
Cardiovasc Intervent Radiol; 2023 Dec; 46(12):1696-1702. PubMed ID: 37902854
[TBL] [Abstract][Full Text] [Related]
6. Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections.
Kaya E; Tollapi L; Pastore A; Aringhieri G; Maisetta G; Barnini S; Paolicchi A; Batoni G; Esin S
J Med Microbiol; 2020 Nov; 69(11):1273-1284. PubMed ID: 33064069
[No Abstract] [Full Text] [Related]
7. Standardized procedure prevents perioperative and early complications in totally implantable venous-access ports-a complication analysis of more than 1000 TIVAP implantations.
Thiel K; Kalmbach S; Maier G; Wichmann D; Schenk M; Königsrainer A; Thiel C
Langenbecks Arch Surg; 2022 Dec; 407(8):3755-3762. PubMed ID: 36070032
[TBL] [Abstract][Full Text] [Related]
8. Outcome of totally implantable venous-access port-related infections.
Vidal M; Genillon JP; Forestier E; Trouiller S; Pereira B; Mrozek N; Aumeran C; Lesens O
Med Mal Infect; 2016 Feb; 46(1):32-8. PubMed ID: 26778362
[TBL] [Abstract][Full Text] [Related]
9. Infections Related to Totally Implantable Venous-Access Ports: Long-Term Experience in One Center.
Ji L; Yang J; Miao J; Shao Q; Cao Y; Li H
Cell Biochem Biophys; 2015 May; 72(1):235-40. PubMed ID: 25542370
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, Safety, and Cost-Effectiveness of Intracavitary Electrocardiography-Guided Catheter Tip Placement for Totally Implantable Venous Access Port.
Liu Z; Zheng X; Zhen Y; Liu X; Lin F; Ye Z; Liu P
Ann Vasc Surg; 2022 Jul; 83():168-175. PubMed ID: 34936891
[TBL] [Abstract][Full Text] [Related]
11. Late complications of totally implantable venous access ports in patients with cancer: Risk factors and related nursing strategies.
Yu XY; Xu JL; Li D; Jiang ZF
Medicine (Baltimore); 2018 Sep; 97(38):e12427. PubMed ID: 30235721
[TBL] [Abstract][Full Text] [Related]
12. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
[TBL] [Abstract][Full Text] [Related]
13. Length of Stay Predicts Risk of Early Infection for Hospitalized Patients Undergoing Central Venous Port Placement.
Tang L; Kim CY; Martin JG; Pabon-Ramos WM; Sag AA; Suhocki PV; Smith TP; Ronald J
J Vasc Interv Radiol; 2020 Mar; 31(3):454-461. PubMed ID: 32007408
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
[TBL] [Abstract][Full Text] [Related]
15. Analysis of related complications of totally implantable venous access ports in children's chemotherapy: Single center experience.
Zhang S; Xiao Z; Yang F
Medicine (Baltimore); 2022 Jul; 101(27):e29899. PubMed ID: 35801731
[TBL] [Abstract][Full Text] [Related]
16. [Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port].
Crisinel M; Mahy S; Ortega-Debalon P; Buisson M; Favre JP; Chavanet P; Piroth L
Med Mal Infect; 2009 Apr; 39(4):252-8. PubMed ID: 19108966
[TBL] [Abstract][Full Text] [Related]
17. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.
Hong S; Seo TS; Song MG; Seol HY; Suh SI; Ryoo IS
J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460
[TBL] [Abstract][Full Text] [Related]
19. Implantable venous access devices in children with severe hemophilia: a tertiary pediatric institutional experience.
Bedoya MA; Raffini L; Durand R; Acord MR; Srinivasan A; Krishnamurthy G; Vatsky S; Escobar F; Cahill AM
Pediatr Radiol; 2020 Jul; 50(8):1148-1155. PubMed ID: 32390060
[TBL] [Abstract][Full Text] [Related]
20. Infection of totally implantable venous access devices: A review of the literature.
Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
